Product Information
LEVOCARNITINE 330 MG TABLET is a generic product labeled by ANI Pharmaceuticals, Inc., priced at $0.6612 per EA under NDC 70954049210. Its NADAC has been published 185 times since Feb 8, 2023.
FDA first approved this application on Dec 9, 2022. Its Orange Book therapeutic-equivalence code is AB — FDA rates it therapeutically equivalent to (substitutable for) its reference product.
Strength
330 mg/1
Manufacturer
ANI Pharmaceuticals, Inc.NDC
70954049210
Classification
Generic
Dosage Form
TABLET
Route
ORAL
Effective Date
8/19/2026
Active Ingredients
LEVOCARNITINEApproval Type
Generic (ANDA)
FDA Application
ANDA216384FDA Approved
12/9/2022
TE Code
AB
On Market Since
12/9/2022
Pharmacological Classes
Price Statistics
The NADAC for LEVOCARNITINE 330 MG TABLET has been published 185 times since Feb 8, 2023, and over the history we have for it it has risen 8.6%. The table below summarizes its recorded NADAC range and movement.
| Current price | $0.6612 per EA |
|---|---|
| All-time high | $0.8677 (Jan 10, 2024) |
| All-time low | $0.4863 (Jul 17, 2024) |
| 52-week high | $0.7556 |
| 52-week low | $0.6433 |
| Median price | $0.7289 |
| Average price | $0.7316 |
| Largest weekly change | +38.5% (Feb 15, 2023) |
| Weeks tracked | 185 |
| Tracking since | Feb 8, 2023 |
Generic Alternatives
The matcher finds 1 manufacturer offering a NADAC-published product with this drug's active ingredient and strength in a comparable dosage form (cheapest from each manufacturer, up to 10 shown below). None of the shown alternatives sit below the current price. These are candidates to verify clinically, not guaranteed substitutes — see our generic drug prices guide.
Related Drugs
Same classification
Frequently asked questions
What is the NADAC price of LEVOCARNITINE 330 MG TABLET?
The current National Average Drug Acquisition Cost (NADAC) for LEVOCARNITINE 330 MG TABLET, manufactured by ANI Pharmaceuticals, Inc., is $0.6612 per EA (NDC 70954049210), effective Aug 19, 2026.
How has the price of LEVOCARNITINE 330 MG TABLET changed over time?
Over the history we have for it, the NADAC for LEVOCARNITINE 330 MG TABLET has risen 8.6%. It has been tracked across 185 weekly CMS publications since Feb 8, 2023.
What are the highest and lowest recorded NADAC prices for LEVOCARNITINE 330 MG TABLET?
Since Feb 8, 2023, the NADAC for LEVOCARNITINE 330 MG TABLET has ranged from a low of $0.4863 (Jul 17, 2024) to a high of $0.8677 (Jan 10, 2024), with a median of $0.7289 per EA.
Are there cheaper alternatives to LEVOCARNITINE 330 MG TABLET?
1 manufacturer publishes a NADAC-priced product with the same active ingredient and strength as LEVOCARNITINE 330 MG TABLET in a comparable dosage form, but none are currently priced below it.
Who manufactures LEVOCARNITINE 330 MG TABLET?
LEVOCARNITINE 330 MG TABLET (NDC 70954049210) is labeled by ANI Pharmaceuticals, Inc., and CMS classifies it as a generic product.